MEI Pharma Inc. has announced a private placement agreement to raise approximately $100 million through the sale of 29,239,767 shares of common stock at $3.42 per share. The proceeds will be dedicated to implementing a Litecoin Treasury Strategy, marking MEI Pharma as the first publicly traded company on a national exchange to hold Litecoin. Charlie Lee, the founder of Litecoin and a lead investor in the transaction, will join MEI's Board of Directors upon closing, replacing current member Taheer Datoo. GSR will oversee the company's digital asset and treasury management. Titan Partners Group is acting as the sole placement agent for this transaction, which is expected to close around July 22, 2025, pending customary closing conditions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.